Clinical trial
IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months…
NCT00316784 · IDEA AG, Industry · Completed
Key facts
| NCT number | NCT00316784 |
|---|---|
| Title | IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA |
| Official title | A Double-Blind, Placebo-Controlled Evaluation of Dose Related Safety and Efficacy of Epicutaneously Applied IDEA-033 for 3 Months Treatment of OA of the Knee Followed by a Double-Blind, Dose-Controlled Evaluation of Safety and Efficacy of Epicutaneously Applied IDEA-033 for 12 Weeks Treatment of OA… |
| Lead sponsor | IDEA AG, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | IDEA-033 (and rescue medication) |
| Enrollment | 704 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Apr 21, 2006 |
| Last update posted | Mar 20, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: